Selected article for: "liver dysfunction and lymph node"

Author: Stark, Caren J; Atreya, CD
Title: Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies
  • Document date: 2005_4_15
  • ID: 0fitbwuv_3
    Snippet: The clinical symptoms of SARS are those of a lower respiratory tract infection and are accompanied by damage to the lungs [6, 9, 10] . Gastrointestinal involvement is also common, with more than 20% of patients presenting with watery diarrhea [11] . Fecal samples from SARS patients taken up to 25 days after onset of disease contain viral RNA, which suggests viral shedding through the bowels [5] . Liver dysfunction has also been reported based on .....
    Document: The clinical symptoms of SARS are those of a lower respiratory tract infection and are accompanied by damage to the lungs [6, 9, 10] . Gastrointestinal involvement is also common, with more than 20% of patients presenting with watery diarrhea [11] . Fecal samples from SARS patients taken up to 25 days after onset of disease contain viral RNA, which suggests viral shedding through the bowels [5] . Liver dysfunction has also been reported based on observed necrosis in hepatocytes [9, 12] . Post-mortem tissue examination of SARS patients has found the virus presence in lung, bowel, lymph node, liver, heart, kidney, and skeletal muscle samples [13] . The primary mode of SARS-CoV transmission is airborne via droplets [14, 15] . However, there are also reports of the presence of replicating virus in blood cells (peripheral blood mononuclear cells) and in the small and large intestine [11, 16] . Alternative modes of transmission, such as blood-borne or fecaloral are therefore possible.

    Search related documents:
    Co phrase search for related documents
    • blood cell and clinical symptom: 1, 2, 3, 4, 5, 6
    • blood cell and disease onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • blood cell and fecal sample: 1, 2
    • blood cell and liver dysfunction: 1, 2, 3, 4
    • blood cell and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • blood cell and peripheral blood mononuclear cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood cell and primary mode: 1
    • blood mononuclear and clinical symptom: 1, 2, 3
    • blood mononuclear and disease onset: 1, 2, 3, 4, 5, 6
    • blood mononuclear and liver dysfunction: 1
    • blood mononuclear and lung damage: 1, 2, 3, 4, 5
    • blood mononuclear and peripheral blood mononuclear cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood mononuclear cell and clinical symptom: 1, 2
    • blood mononuclear cell and disease onset: 1
    • blood mononuclear cell and peripheral blood mononuclear cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical symptom and disease onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • clinical symptom and Gastrointestinal involvement: 1
    • clinical symptom and liver dysfunction: 1, 2, 3, 4
    • clinical symptom and peripheral blood mononuclear cell: 1, 2